What is the recommended action after culture results to optimize antibiotic therapy?

• A. Escalate to broad-spectrum therapy
• B. De-escalate to targeted narrow-spectrum agent and consider shortening duration if appropriate
• C. Stop therapy immediately
• D. Switch to antiviral therapy

Answer: (B)

After culture results, the optimal move is to tailor therapy to the identified organism by de-escalating to a targeted narrow-spectrum antibiotic and, if appropriate, shortening the duration. This approach reduces collateral damage to the normal flora, lowers the risk of resistance, minimizes adverse effects and costs, and preserves broad-spectrum agents for cases where they’re truly needed. Switch from the initial broad empiric regimen to the specific agent that covers the pathogen and its susceptibilities. If the patient is clinically improving and guidelines support shorter courses for the infection, shorten the duration accordingly. If the organism is resistant or not susceptible to narrow options, adjust therapy based on susceptibility and clinical response. Antiviral therapy isn’t indicated for bacterial infections.